Posted in | News | Nanomedicine | Nanobusiness

Competition Award for Groundbreaking Research that Uses DNA Microarray Analysis

Toray Industries, Inc. (TOKYO:3402) of Japan, an integrated chemical industry group developing its business in 21 countries and regions worldwide, announces a competition award for groundbreaking research that uses DNA microarray analysis.

Toray's "3D-Gene™ Competition Award" is donated to encourage further progress and achievements of scientists using DNA microarray technology in research leading to publishing papers of superior quality about analyses using DNA microarray.

3D-Gene™ is a super-sensitive microarray. Toray has succeeded in development of a DNA microarray substrate with high sensitivity (100 times that of existing DNA microarray substrate), high reproducibility/quantification and high speed (10 times the existing substrates) based on its unique technologies such as an agitation method during hybridization using microbeads and a substrate with special configuration and gene spotting technology using nano-level control of molecules.

We seek applicants who are researchers with research plans in which gene expression analyses play an important part. Applicants of any age and affiliation are welcome. The proposed research must make full use of gene expression analysis which 3D-Gene™ could support.

The award winners will get DNA microarray analyses with 3D-Gene™ matched to each winner's research plan and a research grant of $2,000 specially for the sample preparation. The award winner will send their samples to Toray for the analysis. The whole microarray analysis will be done by Toray in Japan (basic data analysis is included).

Applications for this award will be accepted until December 10, 2009.

For details:

Genes are the blueprints of life. A human being is estimated to have 25,000 types of genes. DNA Microarray is a tool that studies the state of these large numbers of genes simultaneously to allow for examining or predicting of the body's mechanisms and a source and condition of illness. Toray is significantly contributing to the actualization of tailor-made medical treatments by shedding light on the new life phenomenon as well as making it possible to gain more gene information from the least amount of samples through the production of the DNA Microarray for research purposes.

Toray Group is an integrated chemical industry group developing its business in 21 countries and regions worldwide. Toray Group fuses nanotechnology into its operations, using organic synthetic chemistry, polymer chemistry and biochemistry as its core technologies. In addition to the Foundation Businesses of fibers & textiles and plastics & chemicals, Toray likewise promotes the global development of IT-related products, carbon fiber composite materials, pharmaceuticals and medical products, environment & engineering including water treatment and progress in other pivotal business fields.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type